Research & regulatory
Development stage, openly stated.
Assistive technology attracts a lot of confident claims. Here’s exactly where we are, including the parts that aren’t finished.
Current status
As at 23 October 2026
-
International patent application filed
PCT/AU2026/050792, filed 24 July 2026. It covers the dual-system architecture and the felt spatial encoding. It publishes in February 2027; until then it is not searchable on public registers.
Filed July 2026
-
Working prototype
Custom hardware, firmware and application, built and iterating: revision 4 runs on the bench, and revision 5, on purpose-designed circuit boards, is in design. Informal feedback has come from people across the vision-loss spectrum, including congenital blindness, macular degeneration and retinitis pigmentosa.
In progress
-
Structured user study
A standardised participant study is being planned, to run under human research ethics approval with independent clinical oversight, in a purpose-built assessment space.
In planning
-
Regulatory classification
Classification under the Australian therapeutic goods framework is being determined with a licensed regulatory consultant, and a written classification opinion is the next step. Formal risk management and Australian electrical and radio certification planning sit alongside it.
Under way
How we talk about evidence
We distinguish carefully between two things that are often blurred together in this field:
- Informal user testing: real people using the prototype and telling us what works. We have this, and it drives the build. It is not clinical evidence.
- Structured study under ethics approval: a defined protocol, independent oversight, pre-specified measures. This is planned, not complete, and we will not describe results before there are results.
When the study is done, we will publish what it found, including anything it fails to show.
Working with us
We’d like to hear from clinicians, orientation and mobility specialists, researchers, and blindness and low-vision organisations, particularly those willing to be sceptical in public. Early, critical review is more useful to us than late, polite agreement.
The ask is small. Tell us what we’ve missed in the design or in the planned study, or just tell us who we should be talking to; even a name helps. There’s nothing to buy or sign, and we’ll share what we learn with you.
Or use the one-minute form on the home page and tick “Work together”.
Development-stage notice. The device is not currently available for supply, and nothing on this site is an offer to sell. Availability information will be published only once development, testing and the applicable regulatory steps are complete.